SGLT2s are currently only approved for use in the U.S. for type 2 diabetes, but a lot of people with type 1 are taking them off label with positive results.
read more →
There are a lot of misconceptions around DKA, or diabetic ketoacidosis. It’s a common but very serious acute complication that develops when someone who is insulin dependent loses access to insulin (your pump line falls out, etc). Drs. Edelman and Pettus explain the causes, symptoms, and treatment.
read more →
A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
read more →
